Alcon AG is a Switzerland-based eye care company. The Company research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Company’s Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Company’s Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The Company operates in 60 countries and serves consumers and patients in over 140 countries.
회사 코드ALC
회사 이름Alcon AG
상장일Apr 09, 2019
설립일2018
CEOMr. David J. Endicott
직원 수25599
유형Ordinary Share
회계 연도 종료Apr 09
주소Rue Louis d'Affry 6
도시FRIBOURG
증권 거래소SIX Swiss Exchange
국가Switzerland
우편 번호1700
전화41589113800
웹사이트https://www.alcon.ch/
회사 코드ALC
상장일Apr 09, 2019
설립일2018
지난 5년 동안 총
400.00M
USD의 배당금이 분배되었습니다.
ALC.NB Final Cash Dividend of gross CHF 0.2 paid on May 05, 2022 going ex on Apr 29, 2022
ALC.NB Final Cash Dividend of gross CHF 0.1 paid on May 06, 2021 going ex on May 04, 2021